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Arrhythmia/Electrophysiology
Cardiac Arrhythmogenic Remodeling in a Rat Model of
Long-Term Intensive Exercise Training
Begon˜a Benito, MD*; Gemma Gay-Jordi, PhD*; Anna Serrano-Mollar, PhD; Eduard Guasch, MD;
Yanfen Shi, MD; Jean-Claude Tardif, MD; Josep Brugada, MD, PhD;
Stanley Nattel, MD†; Lluis Mont, MD, PhD†
Background—Recent clinical studies suggest that endurance sports may promote cardiac arrhythmias. The aim of this
study was to use an animal model to evaluate whether sustained intensive exercise training induces potentially adverse
myocardial remodeling and thus creates a potential substrate for arrhythmias.
Methods and Results—Male Wistar rats were conditioned to run vigorously for 4, 8, and 16 weeks; time-matched
sedentary rats served as controls. Serial echocardiograms and in vivo electrophysiological studies at 16 weeks were
obtained in both groups. After euthanasia, ventricular collagen deposition was quantified by histological and
biochemical studies, and messenger RNA and protein expression of transforming growth factor-1, fibronectin-1,
matrix metalloproteinase-2, tissue inhibitor of metalloproteinase-1, procollagen-I, and procollagen-III was evaluated in
all 4 cardiac chambers. At 16 weeks, exercise rats developed eccentric hypertrophy and diastolic dysfunction, together
with atrial dilation. In addition, collagen deposition in the right ventricle and messenger RNA and protein expression
of fibrosis markers in both atria and right ventricle were significantly greater in exercise than in sedentary rats at 16
weeks. Ventricular tachycardia could be induced in 5 of 12 exercise rats (42%) and only 1 of 16 sedentary rats (6%;
P0.05). The fibrotic changes caused by 16 weeks of intensive exercise were reversed after an 8-week exercise
cessation.
Conclusions—In this animal model, we documented cardiac fibrosis after long-term intensive exercise training, together
with changes in ventricular function and increased arrhythmia inducibility. If our findings are confirmed in humans, the
results would support the notion that long-term vigorous endurance exercise training may in some cases promote adverse
remodeling and produce a substrate for cardiac arrhythmias. (Circulation. 2011;123:13-22.)
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Regular physical activity confers benefits that are widelyrecognized such as improved cardiovascular risk profiles
and prevention of coronary heart disease and diabetes melli-
tus.1,2 Regular exercise also directly and positively affects
cardiac physiology (eg, increased myocardial oxygen supply
and enhanced myocardial contractility), both in the general
population3 and in patients with cardiovascular disease.4
Editorial see p 5
Clinical Perspective on p 22
Long-term exercise induces hemodynamic changes and
alters the loading conditions of the heart, with specific effects
depending on the type of sport and intensity, that are most
evident among athletes.5 Cardiac adaptations in highly trained
subjects include increased left ventricular (LV) and right
ventricular (RV) diameters, enlarged left atrial (LA) dimen-
sions, and increased cardiac mass and LV wall thickness.5,6
These changes, together with a preserved ejection fraction,
have classically characterized the physiology of the “athlete’s
heart.”5
Despite the evident benefits of an active lifestyle,1–4
numerous observational studies have raised concerns that
high-level exercise training may be associated with increased
cardiac arrhythmia risk and even primary cardiac arrest.7
Initial observations from our group and others,8–13 later
confirmed by a large epidemiological study,14 have shown
that long-term endurance training may promote atrial fibril-
lation. Complex ventricular tachyarrhythmias can also occur
in highly trained individuals15; according to recent studies16,17
they often originate from a mildly dysfunctional RV, even
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after excluding RV pathologies like arrhythmogenic RV
cardiomyopathy.
These findings raise the possibility that long-term endur-
ance exercise may promote the development of certain
cardiac arrhythmias. Some authors have speculated that the
cardiac remodeling after sustained physical activity may
create an arrhythmogenic substrate.8,17 Although information
on athletes is insufficient, arrhythmia susceptibility has been
extensively related to myocardial fibrosis in other clinical
contexts.18 Tissue fibrosis appears as a reparative process for
damaged myocardial parenchyma and results in accumulation
of fibrillary collagen deposits, which may favor reentry and
consequently arrhythmogenicity.18
The present study was designed to develop a rat model of
long-term, intensive endurance exercise to test whether reg-
ular intense physical training can induce cardiac structural




This study conformed to European Community (Directive 86/609/
EEC), Spanish, and Canadian guidelines for the use of experimental
animals and was approved by the institutional animal research ethics
committees. Pathogen-free, 4-week-old male Wistar rats weighing
100 to 125 g (Charles River Laboratories, France) were housed in a
controlled environment (12/12-hour light/dark cycle) and fed rodent
chow and tap water ad libitum.
Animals were randomly assigned to sedentary (Sed) or intensive
exercise (Ex) groups. To assess time-course changes, animals in both
groups were studied at 4, 8, and 16 weeks. The exercise program was
based on a previously validated protocol.19 Ex rats underwent daily
running training sessions on a treadmill. The treadmill had different
lanes to serve as corridors for each animal and had a grid in the back
that administered a small electric shock on contact to ensure that
animals ran effectively. The electric shock was of constant intensity
(0.3 to 2 mA), sufficient to encourage the animal to run without
being harmful. The protocol included a 2-week progressive training
program, starting with a 10-minute running session at 10 cm/s and
increasing gradually to steady-state 60-minute running at 60 cm/s.
Thereafter, animals were trained at this level 5 days a week for 4, 8,
or 16 weeks. Investigators observed the treadmill sessions daily to
ensure effective running. Only rats that mastered the running training
and ran spontaneously with a maximum cumulative shock time of 15
seconds per 1-hour training session were included in the study.
Sedentary rats were housed and fed in the same conditions.
An additional series of rats underwent 16 weeks of training
followed by discontinuation of exercise (DEx) to assess the revers-
ibility of exercise-induced changes. DEx rats were assessed after 2,
4, or 8 weeks of exercise cessation. Sedentary rats housed and fed in
the same conditions over the same period served as DEx controls.
Animals were euthanized 3 days after the end of the training
program to avoid immediate responses or after 2, 4, or 8 weeks from
the last running session in the DEx groups. Hearts were quickly
removed; weighed; dissected into LV, RV, LA, and right atrium
(RA); and frozen in liquid nitrogen at 80°C or fixed for histolog-
ical studies. For details on the echocardiography, electrophysiolog-
ical study, tissue imaging, and biochemical studies, see the online-
only Data Supplement.
Statistical Analysis
Data are expressed as meanSEM. Statistical analysis was generally
carried out with 2-way ANOVA with general linear model proce-
dures using a univariate approach. Compound symmetry covariance
structure was used for repeated measures analysis. The sphericity
test, the Mauchly criterion, was used to test for departures from the
assumption of compound symmetry and was consistent with the
sphericity assumption in all instances. For heart weight and hy-
droxyproline experiments, exercise and time point were the main
effects. Morphometric, real-time polymerase chain reaction and
echocardiographic results were analyzed with 2-way, repeated mea-
sures ANOVA, with exercise as 1 main effect and either cardiac
chamber (morphometric and real-time polymerase chain reaction
experiments) or time point (echocardiography) as the repeated
measures main effect. Picrosirius red and hydroxyproline decondi-
tioning studies were analyzed with 1-way ANOVA. In the case of a
significant interaction by 2-way ANOVA or a significant difference
on 1-way ANOVA, Bonferroni-corrected t tests were used to assess
Sed versus Ex group differences. In the absence of interaction,
P values are shown for significant differences in the main effect. Ex
versus Sed immunoblots and electrophysiological testing results
were compared by use of t tests for nonpaired samples. The Fisher
exact test was used to compare frequency variables. SPSS version
17.0 was used for statistical analysis. Detailed specifications of
statistical analysis in each figure are provided in the online-only
Data Supplement. Two-tailed values of P0.05 were considered
significant.
Results
Cardiac Remodeling After Long-Term Intensive
Exercise Training
Cardiac mass was significantly increased by exercise (Figure
1A). Values for individual cardiac chambers, available at 16
Figure 1. A, MeanSEM cardiac mass
changes indicated by heart weight/body
weight (HW/BW) ratios (Sed: n4, 4, and
6 for 4, 8, and 16 weeks, respectively;
Ex: n5, 5, and 8 for 4, 8, and 16
weeks; 2-way ANOVA). B, Schema indi-
cating areas studied for ventricular hy-
pertrophy assessment. C, MeanSEM
ventricular wall thickness (WT) indexed
to body weight (n4 rats per group;
2-way ANOVA, repeated
measureregion).**P0.01,***P0.001,
Bonferroni-adjusted t test (correction
factor3), Ex vs Sed.
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weeks, were significantly increased in Ex rats (Table 1). No
significant changes were observed in the LV/RV mass ratio.
Direct measurement of wall thickness (Figure 1B) confirmed
significant increments in postmortem interventricular septum
(IVS) and LV free wall (FW) thickness after 8 weeks of
intensive exercise, which were maintained at 16 weeks
(Figure 1C). No significant differences were observed in RV
FW thickness.
To evaluate further cardiac morphological and functional
adaptation to long-term intensive exercise, serial echocardio-
grams were performed in a subset of Ex and Sed rats. Because
morphological LV hypertrophy was not observed before 8
weeks, echocardiograms were performed only at baseline and
after 8 and 16 weeks of training. Ex rats developed concentric
LV hypertrophy at 8 weeks, manifested by increased LV wall
thicknesses and ratio of IVS to LV diameter at end diastole
(for echocardiographic results, see Table 2), evolving to
eccentric hypertrophy/ventricular dilatation at 16 weeks. Ex
rats also showed evidence of LV diastolic dysfunction at 8 to
16 weeks (decreased S wave in pulmonary vein flow, in-
creased LV isovolumic relaxation time corrected for R-R),
along with LA enlargement. A slight but statistically signif-
icant decrease in LV systolic function was also observed in
Ex rats at 16 weeks. Evidence of RV diastolic dysfunction
also occurred at 8 to 16 weeks (decreased E-wave velocity,
prolonged E-wave deceleration time).
Intensive Exercise Training Promotes
Chamber-Specific Ultrastructural Remodeling
We next evaluated tissue fibrosis. Figure 2A shows represen-
tative photomicrographs of Picrosirius red–stained RV sec-
tions from Sed and Ex rats. Diffuse interstitial collagen
deposition associated with disturbances in myocardial archi-
tecture was observed in RV FWs of Ex rats after 16 weeks of
training. No differences were observed in the LV (Figure IA
in the online-only Data Supplement). Morphometric quanti-
fication confirmed a gradual increase in RV FW collagen
with training (Figure 2B). No differences in collagen density
Table 1. Tissue Mass in Sed and Ex Rats After 16 Weeks of
Training
Sed Rats (n9) Ex Rats (n10)
RA/BW, g/kg 0.0910.006 0.1440.020*
LA/BW, g/kg 0.0830.010 0.1530.020†
RV/BW, g/kg 0.3570.019 0.4330.029*
LV/BW, g/kg 1.8370.057 2.2120.098†
IVS, g/kg 0.4440.026 0.6440.100
LV FW, g/kg 1.3940.052 1.5680.160
LV/RV mass index 5.2270.259 5.2640.329
BW indicates body weight.
*P0.05, †P0.01, nonpaired t test, Ex versus Sed rats.
Table 2. Serial Echocardiographic Parameters in the Ex and Sed Groups
Baseline At 8 wk At 16 wk
Sed (n11) Ex (n12) Sed (n11) Ex (n12) Sed (n11) Ex (n12)
LV dimensions and function
LVDd/BW, cm/kg 3.010.07 3.010.05 1.590.04 1.720.03 1.390.05 1.630.02‡
LVDs/BW, cm/kg 1.430.07 1.510.06 0.790.03 0.860.03 0.720.03 0.940.03†
IVS/BW, cm/kg 0.550.01 0.560.01 0.310.01 0.380.01‡ 0.290.01 0.360.01‡
PW/BW, cm/kg 0.540.01 0.540.01 0.300.01 0.350.01† 0.270.01 0.320.01‡
LV mass/BW, g/kg 2.680.11 2.680.07 1.930.04 2.140.05 1.760.06 2.130.07†
IVS/LVDd* 0.190.01 0.190.00 0.200.01 0.220.00 0.210.01 0.220.01
EF, % 86.991.45 85.191.31 85.740.92 85.661.02 83.851.02 77.891.54†
S-wave PV, cm/s 32.441.53 32.711.53 33.391.48 31.931.45 37.061.46 30.451.20†
IVRTc, ms 1.210.06 1.120.07 1.210.06 1.430.07* 1.290.05 1.490.06
RV dimensions and function
RVD/BW, cm/kg 1.290.03 1.270.05 0.680.02 0.720.03 0.600.02 0.690.02
RVWT/BW, cm/kg 0.100.02 0.110.03 0.060.01 0.060.01 0.060.01 0.070.01
TAPSE, cm 3.380.68 3.160.14 3.410.11 3.610.09 3.800.09 3.430.09
Sm, cm/s 8.130.68 8.570.40 9.420.45 9.210.47 10.370.59 8.990.36
E velocity, cm/s* 75.603.51 74.882.31 76.615.50 60.764.27 63.813.63 49.553.41
E-DT, ms 36.541.48 33.152.07 34.431.39 35.693.28 28.492.04 44.074.31‡
E/A ratio 1.080.06 1.200.07 1.030.05 0.880.07 1.030.06 0.870.05
Atrial dimensions
LADs/BW, cm/kg 1.830.04 1.870.03 0.980.03 1.130.02† 0.890.03 1.140.02‡
LVDd indicates LV diameter at end diastole; BW, body weight; LVDs, LV diameter at end systole; PW, posterior wall thickness; EF, ejection fraction; PV, pulmonary
vein; IVRTc, LV isovolumic relaxation time corrected for R-R; RVD, RV diameter at end diastole; RVWT, RV wall thickness; TAPSE, tricuspid annulus plane systolic
excursion; Sm, RV lateral wall systolic motion velocity; E-DT, E-wave deceleration time; and LADs, LA diameter at end-systole.
*P0.05, †P0.01, ‡P0.001, Ex rats versus Sed rats, 2-way repeated measures ANOVA.
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were observed in the IVS or LV FW. Increased collagen in
the RV of Ex rats at 16 weeks was also noted on Masson
trichrome–stained images (Figure 3A).
To independently quantify fibrous tissue content, the
amount of hydroxyproline, a modified amino acid specifically
found in collagen, was determined. After 16 weeks of
intensive exercise, animals showed significant increases in
RV hydroxyproline content (Figure 3B), with no significant
differences observed in the LV (Figure I in the online-only
Data Supplement).
Messenger RNA (mRNA) expression of transforming growth
factor-1 (TGF-1), fibronectin-1, matrix metalloproteinase-2
(MMP-2), tissue inhibitor of metalloproteinase-1 (TIMP1),
procollagen-I, and procollagen-III was measured in all cardiac
chambers of rats in the Sed and Ex groups. After 4 and 8
weeks of exercise, no significant changes were observed
(Table I in the online-only Data Supplement). The results at
16 weeks are shown in Figure 4. TGF-1, fibronectin-1, and
MMP-2 mRNA expression was significantly increased in the
RA, LA, and RV of Ex rats compared with Sed rats (Figure
4A, 4B, and 4C, respectively). The only significant difference
for TIMP1 mRNA expression was found in the RA (Figure
4D). Finally, mRNA expression of procollagen-I was signif-
icantly increased in the RA and RV of Ex rats (Figure 4E),
whereas procollagen-III was significantly increased in both
the RA and LA of Ex rats (Figure 4F).
Alterations in protein expression corresponding to mRNA
changes were assessed by Western blot analysis for TGF-1,
fibronectin-1, MMP-2, TIMP1, collagen-I, and collagen-III.
TGF-1 protein levels were significantly increased in both
atria and RVs of Ex rats (Figure 5A). Fibronectin showed no
significant changes (Figure 5B). MMP-2 protein expression
was significantly increased in the RA and LA of Ex rats
(Figure 5C), whereas TIMP1 was unchanged (Figure 5D). In
parallel with results for procollagen-I mRNA expression,
collagen-I protein levels were significantly greater in both the
RA and RV of Ex rats (Figure 5E); however, collagen-III was
unchanged (Figure 5F).
These results confirm the development of significant ex-
tracellular matrix (ECM) changes after 16 weeks of intensive
endurance exercise, with fibrosis clear in the RV but not LV.
Figure 2. A, Picrosirius-stained photomi-
crographs of RV sections. In 16-week Ex
rats, there is widespread interstitial colla-
gen deposition with disarray of myocar-
dial architecture (arrow). B, MeanSEM
collagen content in RV FW, IVS, and LV FW
(n4 per group/time point; 2-way ANOVA,
repeated measureregion).*P0.05,
Bonferroni-adjusted t test (correction fac-
tor3), Ex vs Sed.
Figure 3. A, Masson trichrome–stained photomicrographs of
right ventricular sections. Increased collagen deposition (blue
staining, arrow) is present in the Ex group at 16 weeks. B,
MeanSEM hydroxyproline content in the RV FW. n4 (Sed at
4 and 8 weeks), n6 (Sed at 16 weeks), n5 (Ex at 4 and 8
weeks), and n8 (Ex at 16 weeks); 2-way ANOVA, no repeated
measures.***P0.001, Bonferroni-adjusted t test (correction fac-
tor3), Ex vs Sed.
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Long-Term Intensive Exercise Increases
Ventricular Arrhythmia Vulnerability
We then evaluated whether ventricular remodeling by 16
weeks of exercise led to changes in electrophysiological
parameters and/or arrhythmia susceptibility. In vivo electro-
physiological study was performed with a customized cathe-
ter inserted into the RV apex. Ex rats showed evidence of a
slight delay in ventricular conduction, manifested by longer
QRS duration (Table 3). No changes were noted in repolar-
ization on the basis of ventricular effective refractory periods.
During programmed stimulation with up to 3 extrastimuli,
sustained ventricular tachyarrhythmias (10 seconds) were
induced in 5 of 12 Ex rats (42%) compared with 1 of 16 Sed
rats (6%; P0.05; Figure 6).
Remodeling Reverses With Detraining
To determine whether potentially adverse ventricular remod-
eling is reversible after exercise cessation, we compared rats
allowed to recover after discontinuation of exercise (DEx
groups) with age-matched Sed controls. Although showing
some regression, cardiac mass remained significantly greater
in all DEx groups compared with their Sed counterparts
(Figure 7A).
Because all Sed groups (Sed at 16 weeks and Sed-DEx at
2, 4, and 8 weeks) presented equivalent data (not shown) for
morphometric measurements, hydroxyproline levels, histol-
ogy, and mRNA analyses, results for the 16-week Sed group
were used for comparisons. Wall thickness increases induced
by 16 weeks of intensive exercise resolved progressively in
both the IVS and LV FW (Figure 7B). In contrast, no
differences in RV wall thicknesses were found among the Ex,
the Sed and all the DEx groups.
We then evaluated whether the fibrotic changes induced by
16 weeks of intensive exercise were also reversed by exercise
discontinuation. Histopathology studies with Masson
trichrome and Picrosirius red confirmed a gradual decrease in
collagen content during deconditioning (Figure 7C and 7D).
Similarly, collagen quantification based on image analysis of
Figure 4. MeanSEM mRNA-expression of fibrotic markers (A)
TGF-1, (B) fibronectin-1, (C) MMP-2, (D) TIMP1, (E)
procollagen-I (Proc-1), and (F) procollagen-III (Proc-III) at 16
weeks in the Sed and Ex groups, quantified by real-time poly-
merase chain reaction and normalized to -actin. n6 (Sed)
and n8 (Ex); 2-way ANOVA, repeated measureregion.
*P0.05,**P0.01,***P0.001, Bonferroni-adjusted t test (cor-
rection factor4), Ex vs Sed.
Figure 5. MeanSEM protein levels of fibrotic markers (A) TGF-
1, (B) fibronectin-1, (C) MMP-2, (D) TIMP1, (E) collagen-I (Col-
I), and (F) collagen-III (Col-III) analyzed by immunoblot (exam-
ples shown above bar graphs) and normalized to -actin in the
Sed and Ex groups at 16 weeks. n6 (Sed) and n8 (Ex); non-
paired t test,*P0.05,**P0.01, Ex vs Sed.
Table 3. Ventricular Electrophysiological Parameters at 16
Weeks
Sed Rats (n10), ms Ex Rats (n11), ms
QRS duration 23.50.4 25.20.6*
V-duration 17.10.5 18.20.6
VERP 39.81.1 43.21.3
V-duration indicates ventricular electrogram duration; VERP, ventricular
effective refractory period.
*P0.05, non-paired t test, Ex versus Sed group.
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Picrosirius red–stained tissues confirmed regression of fibro-
sis in the RV after deconditioning (Figure 7E). Correspond-
ingly, hydroxyproline content in RV decreased progressively
during deconditioning and became nonsignificantly different
from Sed rats and significantly lower than in Ex rats at 16
weeks after exercise cessation (Figure 7F). In accordance
with these results, mRNA studies showed significant reversal
in exercise-enhanced profibrotic markers within 2 weeks of
deconditioning (Figure 8). Together, these results suggest
substantial reversibility of vigorous endurance training–in-
duced cardiac remodeling after the cessation of exercise
training.
Discussion
The present study describes cardiac remodeling in a rat model
of long-term, intensive exercise training, demonstrating
changes in cardiac function, fibrous tissue content, fibrotic
markers, and arrhythmia susceptibility following long-term
endurance training, with substantial reversibility after exer-
cise cessation. If results are similar in humans, then our
findings suggest that long-term, intensive exercise can pro-
mote chamber-specific remodeling and provide a substrate
for arrhythmogenesis.
Cardiac Remodeling After Intense
Endurance Exercise-Training
As previously described in other models,19–21 we found
significant LV hypertrophy at 8 weeks of training. At 16
weeks, LV dilatation was also observed, leading to eccentric
Figure 6. A, Inducibility of sustained (10 seconds) ventricular
arrhythmias by programmed electric stimulation; Fisher exact
test, Ex vs Sed. B, Example of polymorphic ventricular
tachyarrhythmias (VT) induction by ventricular stimulation in an
Ex rat.
Figure 7. Reversibility of remodeling.
Sed indicates time-matched sedentary
control for 16-week Ex and 2-, 4-,
8-week exercise cessation groups in A
and time-matched sedentary control for
16-week Ex in B through F. A,
MeanSEM heart weight/body weight
(HW/BW) ratio (2-way ANOVA, no
repeated measure; Bonferroni correction
factor7). B, MeanSEM wall thickness/
body weight ratio (2-way ANOVA,
repeated measureregion; Bonferroni
correction factor21). C, Right ventricu-
lar Masson trichrome–stained photomi-
crographs. D, Picrosirius red–stained
photomicrographs. E, MeanSEM colla-
gen content (Picrosirius red). F,
MeanSEM hydroxyproline content
in RV. E and F analyses: 1-way
ANOVA; Bonferroni correction
factor7.*P0.05,**P0.01,***P0.001,
Ex vs Sed. †P0.05,††P0.01,
†††P0.001, DEx vs Ex, Bonferroni-
adjusted t test.
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hypertrophy. LV hypertrophy may have accounted for the
impaired diastolic function observed after 8 and 16 weeks of
exercise, which in turn was associated with LA dilatation. All
these findings are consistent with the features of the athlete’s
heart described in humans5 and support the potential rele-
vance of our training program. Of note, we also observed RV
diastolic dysfunction, with a trend to RV dilatation and
systolic dysfunction after 16 weeks of exercise, findings that
have recently been described in high-level endurance-sport
practitioners.17
Chamber-Specific Myocardial Fibrosis After
Intensive Exercise Training
Perhaps our most noteworthy finding is the demonstration of
myocardial fibrosis after long-term, intensive exercise train-
ing. RV fibrosis was documented by collagen quantification
in histological sections and analysis of hydroxyproline con-
tent. These observations were functionally paralleled by the
development of RV diastolic dysfunction, with impaired
relaxation potentially related to fibrotic infiltration. More-
over, we noted an increase in mRNA and protein expression
of a series of fibrotic markers in the RV and in both atria.
TGF-1 expression was increased in the RA, LA, and RV
after 16 weeks of intensive exercise. TGF-1 is a potent
stimulator of collagen-producing cardiac myofibroblasts22
and leads to fibrosis development. Experimental studies have
reported that both genetic ablation of TGF-1 in mice23 and
treatment with anti–TGF-1 antibodies24 inhibit fibrosis de-
velopment, indicating that TGF-1 plays a major role in
collagen turnover. We also noted enhanced expression of
other major components of the ECM control system, includ-
ing fibronectin-1, collagens, MMP-2, and TIMP1. Collagen-I
determines the stiffness of cardiac muscle, whereas collagen-
III is more distensible. Thus, the ratio of collagen-I to
collagen-III can be a marker of the ECM determinants of
cardiac stiffness.25 We observed a significant increase in
collagen-I protein expression in right-sided cardiac chambers
after 16 weeks of intensive exercise, whereas collagen-III
expression remained unchanged, indicating that long-term,
intensive exercise could increase cardiac stiffness in these
chambers via altered ECM composition, a notion that was
supported by echocardiographic evidence of diastolic dys-
function. These findings were accompanied by overexpres-
sion of mRNA and protein levels of MMP-2. MMP-2 is a
proteolytic enzyme; activation of MMP-2 induces disruption
of ECM proteins and promotes fibrogenesis. Together, these
Figure 8. MeanSEM mRNA expression
of fibrotic markers (A) TGF-1, (B)
fibronectin-1, (C) MMP-2, (D) TIMP1, (E)
procollagen-I (Proc-I), and (F)
procollagen-III (Proc-III) at 16 weeks in
the Sed and Ex groups and in all DEx
groups, quantified by real-time polymer-
ase chain reaction and normalized to
-actin. n4 (Sed) and n6 (Ex and
all DEx groups). Two-way ANOVA,
repeated measureregion.
*P0.05,**P0.01,***P0.001,
Bonferroni-adjusted t test (correction
factor7) for main-effect group
comparisons.
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results indicate the presence of a milieu favoring the devel-
opment of myocardial interstitial fibrosis, characterized by
alterations in fibroblast growth factors and ECM imbalance.
Although extensive data have been published on echocar-
diographic remodeling with exercise,6,26 less information is
available on cardiac histological and biochemical remodeling
in endurance athletes. A recent study demonstrated increased
turnover of fibrosis markers in plasma from veteran ath-
letes,27 although cardiac origin was not assessed. Data in
abstract form also suggest the development of ventricular
fibrosis based on magnetic resonance imaging in endurance
athletes.28 Our finding of cardiac fibrosis represents the first
direct evidence of potentially adverse cardiac remodeling
after long-term, intensive exercise.
The mechanisms by which long-term, intensive exercise
may promote cardiac fibrosis are unknown. It is possible that
long-term cardiac overload plays a role by promoting phys-
iological remodeling in early phases that may eventually
become maladaptive in the long term. Experimental studies
support the idea that physiological cardiac remodeling and
pathological cardiac remodeling involve different signaling
pathways,29 but recent data have demonstrated that excessive
stimulation of physiological systems can result in maladap-
tive responses.30,31 Whether this or other mechanisms are
involved in the profibrotic cardiac remodeling observed in
our model is a matter to be addressed in future studies.
Of note, tissue fibrosis in this model of long-term, inten-
sive exercise was chamber specific (ie, the LV did not appear
to be affected). There are 2 potential explanations for this
finding. First, assuming that exercise increases loading con-
ditions on all cardiac chambers,5 it is reasonable to suppose
that greater profibrotic remodeling develops in chambers
suffering greater degrees of overload. In this regard, clinical
studies have described higher loading conditions on the RV
than on the LV during endurance sports,32 leading to transient
RV dysfunction immediately after exercise.33 Second, it has
been suggested that intrinsically thinner walls could make the
atria, as well as the RV, more susceptible to remodeling.17,18
The absence of significant fibrosis in the LV agrees with
previous models of long-term exercise20,21 and supports the
normal functionality of the LV of the athlete’s heart.5
Supporting this idea, an animal model of long-term volume
overload with similarities to loading condition changes in
endurance training showed regional overexpression of growth
factors and increased collagen deposition in the RV but not
the LV.34
Intense Exercise Training and
Arrhythmogenic Remodeling
Despite its benefits for overall health,1–4 numerous clinical
studies in recent years have suggested that long-term high-
level exercise might be associated with an increased risk of
cardiac arrhythmias, mainly atrial fibrillation and ventricular
arrhythmias originating from the RV.8–16 One important
aspect of this study is that the remodeling observed after
long-term, intensive exercise training could represent a po-
tential substrate for arrhythmias. Cardiac fibrosis and associ-
ated myocardial disarray provide electric heterogeneity and
promote reentrant circuits and arrhythmogenesis.18 It has
been reported that atrial overexpression of TGF-1 in trans-
genic mice is sufficient to generate a fibrotic substrate that
supports atrial fibrillation.35 Similarly, increases in procolla-
gen and MMPs have been related to increased risks of atrial
and ventricular arrhythmias.36–38 We assessed this hypothesis
by evaluating the inducibility of ventricular arrhythmias
during in vivo programmed stimulation studies and noted
inducible sustained ventricular tachyarrhythmias in 42% of
rats subjected to intensive exercise for 16 weeks, compared
with only 6% of sedentary rats. In the presence of increased
QRS duration, indicating ventricular conduction slowing, and
the absence of changes in electrophysiological parameters
reflecting repolarization-like ventricular refractory period,
these results suggest that the cardiac fibrosis observed in our
model could play a role in producing the increased arrhyth-
mia susceptibility we observed in exercise rats.
Reversibility
Clinical studies have reported regression of the morphologi-
cal changes characteristic of the athlete’s heart after long-
term detraining.39 The reversibility of arrhythmogenic remod-
eling is of potentially great clinical importance, because it
would imply that deleterious rhythm consequences of long-
term endurance training can be expected to disappear after
cessation of intense physical training. We accordingly as-
sessed whether a period of rest could allow reversion of the
profibrotic changes induced by endurance training in our
model. The results of our exercise discontinuation study
demonstrate that, after 8 weeks of detraining, virtually all the
abnormal cardiac remodeling parameters resulting from in-
tense exercise training regressed to control levels.
More studies are needed to ascertain the mechanisms that
participate in both the promotion and the reversal of the
fibrotic remodeling associated with long-term exercise and
detraining, respectively. In addition, follow-up clinical stud-
ies are indicated to establish whether similar remodeling
changes can be demonstrated in humans and, if so, whether
they are reversible.
Potential Limitations
We cannot exclude the possibility that our exercise training
protocol involving conditioning shocks might have induced
emotional stress in Ex rats. Maximum efforts were taken to
minimize stress responses. Rats that did not adapt to treadmill
exercise or received excessive shocks (15 s/h) were ex-
cluded from the study.
It is difficult to estimate precisely how our exercise
program translates into human activity. As a rough approxi-
mation, considering that the typical rat life expectancy is 2 to
2.5 years, our 18-week exercise protocol (2 weeks of pro-
gressive training plus 16 weeks of intensive exercise) would
be equivalent to 10 years of daily exercise training in
humans. According to previous studies in rodents,40,41 the
intensity of our program would correspond to 85% of
maximum oxygen uptake, equivalent to physical activity at
90% of predicted maximum heart rate in humans.42 There-
fore, our results cannot be directly extrapolated to milder or
more moderate forms of exercise. In addition, we studied
only remodeling reversal with complete exercise cessation,
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which is unlikely in high-level athletes. Whether similar
recovery is achieved by simply reducing the intensity of a
training program is uncertain.
Only young male rats were tested in this study. Age- and
gender-related factors could significantly influence exercise-
related cardiac remodeling and were not analyzed in our
study. Further work in other animal models, studies of age
and gender effects on exercise-induced remodeling, and
follow-up analyses in human populations would be of great
interest.
The functional consequences of cardiac remodeling have
been specifically assessed by passive pressure-strain curves
in papillary muscles or LV pressure-volume curves.43 Be-
cause of limited availability of hearts and the need to obtain
tissue samples for histological and biochemical studies, we
decided to study both functional and morphological conse-
quences of long-term intensive exercise by performing serial
echocardiograms, thus obtaining a maximum of information
while being able to use each rat as its own control.
Conclusions
This study shows that long-term intense endurance training
promotes heart chamber-specific remodeling and ventricular
arrhythmia susceptibility in an animal model. Cessation of
endurance training was able to arrest and even reverse this
pathological process. These findings, if reproduced in hu-
mans, could have potentially important implications for
arrhythmia risk and its management in individuals involved
in high-level athletic training and practice.
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CLINICAL PERSPECTIVE
Despite the well-recognized benefits of exercise training in healthy individuals and in patients with cardiovascular disease,
increasing evidence has suggested that long-term high-level exercise practice (as in athletic contexts) can increase the risk
of developing cardiac arrhythmias. Both atrial tachyarrhythmias (particularly atrial fibrillation) and (much more rarely)
potentially malignant ventricular arrhythmias have been associated with sustained high-level endurance training. There
have been debates about whether these arrhythmias are due to undiagnosed underlying cardiac arrhythmogenic diseases,
with long-term exercise being a triggering factor, or whether high-intensity long-term exercise can actually be a primary
cause of arrhythmia susceptibility. To provide insights into the ability of sustained high-level exercise to cause
arrhythmogenic cardiac remodeling, we applied an experimental model in which male rats were trained to run vigorously
1 hour daily for 16 weeks and compared them with a parallel group of sedentary control rats. We found that intense
long-term exercise induced morphological and functional changes characteristic of the “athlete’s heart” as described in
humans, along with extracellular matrix changes and fibrosis affecting all chambers except the left ventricle. Ventricular
arrhythmia susceptibility to programmed electric stimulation was enhanced in exercise-trained rats. The fibrotic changes
caused by 16 weeks of vigorous exercise training were reversible within several weeks of exercise cessation. These results,
if confirmed in humans, suggest that long-term vigorous endurance exercise training may cause cardiac remodeling that
serves as a substrate for arrhythmia vulnerability. Our findings may have important potential implications for arrhythmia
risk assessment and management in individuals performing high-level exercise training.
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Transthoracic echocardiographic studies were performed at baseline, 8 weeks, and 16 weeks 
in both exercise (Ex) and sedentary (Sed) groups, in all cases with the rats having been at rest 
during a minimum of 6 hours. The procedure was performed under general anesthesia with 
2% isoflurane, using a phased-array probe 10S (4.5-11.5 Megaherz) in a Vivid 7 Dimension 
system (GE Healthcare Ultrasound, Horten, Norway). The M-mode spectrum was traced in 
parasternal long axis view at the level of the aortic valve, left atrial dimension at end-cardiac 
systole (LADs) and right ventricular (RV) dimension (RVD) and wall thickness (RVWT) at end-
cardiac diastole were measured in this view. The M-mode spectrum was also obtained in 
parasternal short axis view at the level of papillary muscle, and left ventricular (LV) dimension 
at both end-cardiac diastole (LVDd) and systole (LVDs) were measured. The thickness of LV 
anterior wall and that of LV posterior wall at end-cardiac diastole were also measured in this 
view. Given that animals differed in size during the study, all dimensions were indexed for 
body weight. LV mass was calculated and corrected for small animals using the formula 
suggested by Reffelmann et al.1 The Teicholz method was employed to calculate LV volumes 
(LVV = (7/(2.4+D))*D3, where D is LV diastolic and/or systolic dimension). LV ejection fraction 
(EF) was calculated using the formula packed in the Vivid 7 system ((LVVd-LVVs)/LVVd*100).  
Pulsed-wave Doppler (PW) was used to record trans-mitral, trans-tricuspid, and pulmonary 
venous flow (TMF, TTF, PVF) in apical 4-chamber view. Peak velocity in early filling E and E 
wave deceleration time (E DT) were measured in TMF and TTF, and peak velocity in systolic 
S wave and diastolic D wave were measured in PVF. Mitral lateral, septal, and tricuspid lateral 
annulus moving velocity during early filling Em were derived by tissue Doppler imaging (TDI) in 
apical 4-chamber view. Tricuspid annulus plane systolic excursion (TAPSE) was measured by 
M-mode echocardiography, and RV lateral wall systolic moving velocity Sm was obtained by 
TDI in apical 4-chamber view. Continuous-wave (CW) Doppler at the conjunction of LV inflow 
and outflow was recorded in apical 5-chamber view, LV isovolumic relaxation time (IVRT) was 




measured, and corrected (IVRTc) by R-R intervals taken from simultaneously recorded 
ECGs.2 The average of 3 consecutive cardiac cycles was used for each measurement, with 
the operator being blinded to treatment assignment. Special care was taken to get similar 
imaging at follow up study.  
 
In vivo electrophysiological study 
At 16 weeks, a subgroup of rats from Ex and Sed groups underwent in vivo 
electrophysiological study (EPS). The procedure was performed under general anesthesia 
with 2% isoflurane. After analgesia with buprenorphine (0.03-0.05 mg/Kg), a 1.9F octapolar 
electrocatheter (Scisense FTS-1913A-1018, London (ON), Canada) was introduced into the 
right ventricle through the right jugular vein. Surface ECG (lead I) and intracardiac 
electrograms were recorded on a computer through an analog-digital converter (IOX 1.585, 
EMKA Technologies, Paris, France) for monitoring and later analysis and measurement. 
Programmed right-ventricular stimulation was performed at a cycle length of 150 ms to 
determine the ventricular effective refractory period (VERP). QRS duration and the duration of 
the ventricular intracavitary electrogram were measured as indices of ventricular conduction. 
For assessment of inducibility of ventricular arrhythmias, double and triple extrastimulation 
techniques were administered to a minimal coupling interval of 30 ms, during spontaneous 
sinus rhythm and following a 9-beat train at a cycle length of 150 ms. Right-ventricular burst 
pacing at rates of 80 to 60 ms cycle length was also performed if no sustained arrhythmias 
were induced with 2-3 extrastimuli. Sustained ventricular tachycardia (VT) was defined as 
episode of ventricular arrhythmia lasting ≥ 10 s induced by ventricular stimulation. 
 
Histology and morphometry 
Total cardiac mass was assessed by heart-weight-to-body-weight ratio. Individual-chamber 
mass was assessed by chamber-weight-to-body-weight ratios. Relative LV to RV hypertrophy 




was evaluated according to the formula proposed by Fulton (LV free-wall (FW) 
weight+interventricular-septum (IVS) weight/RV weight).3  
For histological studies, the hearts were perfused with a fixative solution (10% neutral-buffered 
formalin) at a pressure of 80 cm H2O, immersed in the fixative for 12 – 24 h, and embedded in 
paraffin. Ventricular hypertrophy was evaluated morphometrically by direct measurement of 
ventricular wall thickness in all the heart sections (analySIS Image Processing software, Soft 
Imaging System, Germany) at RV FW, IVS and LV FW levels. Differences in ventricular-size 
were controlled by indexing wall-thickness to body-weight.  
Heart sections were stained with Masson’s trichrome to identify connective tissue and collagen 
deposition. Additionally, sections from the RV and LV were stained with picrosirius-red for 
quantification of collagen deposition using analySIS Image Processing software (Soft Imaging 
System GMBH, Germany), as previously described.4 Perivascular collagen was excluded from 
this measurement.  
 
Hydroxyproline content 
Ventricular hydroxyproline content was measured using the method described by Woessner.5 
Samples of RV and LV were homogenized and then hydrolyzed in 6M HCl for 18 h at 110ºC. 
The hydrolysate was then neutralized with 2.5M NaOH and analyzed for hydroxyproline 
content after addition of chloramine T, perchloric acid and dimethylaminobenzaldehyde. 
Samples were read for absorbance at 550 nm in a spectrophotometer. Results are expressed 
as µg of hydroxyproline per mg dried tissue sample.  
 
mRNA analysis 
Total RNA was extracted from 50 to 100 mg of a section of the right atrium (RA), left atrium 
(LA), RV and LV using Trizol® reagent (Invitrogen Corporation, CA, USA) according to the 
manufacturer's protocol. RNA integrity and loading amounts were assessed by examining 




UV/VIS at a multiple wave lengths following the ND-3300 user manual V2.5, instructions (ND-
3300, NanoDrop Technologies, USA). Analysis of transforming growth factor-β1 (TGF-β1), 
Fibronectin-1, metalloproteinase 2 (MMP2), tissue inhibitor of metalloproteinases 1 (TIMP1), 
procollagen-1 (Proc-I) and procolagen-3 (Proc-III) mRNA expression was obtained by Real-
Time PCR. One μg total mRNA was converted to cDNA with the iScript cDNA (Bio-Rad 
Laboratories, CA, USA) according to the manufacturer’s protocol. 100 ng of cDNA was 
amplified by the iCycler IQTM version 3.1 (Bio-Rad Laboratories, CA, USA) using Applied 
Biosystems (Applied Biosystems, CA, USA) TaqMan gene expression assays (Rn00572010-
m1 for TGF-β1, Rn00569575-m1 for fibronectin, Rn02532334-s1 for MMP2, Rn00587558-m1 
for TIMP1, Rn01526721-m1 for Proc-I, Rn01437675-m1 for Proc-III and Rn00667869-m1 for 
Actin, which was used as a housekeeping reference). Data were analyzed with the ΔCt 
method as previously described.6 
 
SDS-PAGE and Western blot 
Protein samples were extracted using Nonidet P-40 buffer. SDS-PAGE was performed on 5%-
13% acrylamide gels. Proteins were electrotransferred to nitrocellulose membrane and probed 
with primary antibodies. The antibodies used included mouse monoclonal anti-TGF-β1 
(ab27969, dilution1/2000), mouse monoclonal anti-MMP2 (ab7032 dilution 1/1000), rabbit 
polyclonal to TIMP1 (ab61224 dilution 1/1000), mouse monoclonal to collagen-I (ab6308 
dilution 1/1000) (all of them acquired from Abcam plc, Cambridge, UK); rabbit polyclonal anti-
fibronectin ( BP8025, dilution 1/1000) (Acris Antibodies GmbH, Herford, Germany) and rabbit 
polyclonal to collagen-III (dilution 1/500) (Santa Cruz Biotechnology, Ca, USA), and mouse 
monoclonal anti-actin (dilution (1/1000) (Chemicon-Millipore Co, MA, USA), which served as a 
housekeeping reference. The membranes were incubated with the corresponding peroxidase-
conjugated secondary antibodies, washed, and then incubated with ECL reagents (GE 
Healthcare Europe GmbH; Freigburg; GE) before exposure to high performance 




chemiluminescence films. Gels were calibrated using Bio-Rad standard proteins (Hercules, 
CA) with markers covering a 7-240 kDa range. 
Films were scanned by using image-editing software NIH ImageJ software for densitometric 
analysis of immunoreactive bands.  
 
Statistical analysis 
Data are expressed as mean±SEM. Statistical analysis was generally carried out with two-way 
ANOVA using general linear models (GLM procedures), with the exceptions described in detail 
below. In the case of a significant interaction by 2-way ANOVA or a significant difference on 1-
way ANOVA, Bonferroni-corrected t-tests were used to assess Sed versus Ex group-
differences, except as otherwise indicated. All P-values shown were obtained by multiplying 
the P value for the non-paired t-test by the correction factors indicated below. In the absence 
of interaction, P-values are shown for significant main-effect differences. Ex versus Sed 
immunoblots and electrophysiological-testing results were compared with t-tests for non-paired 
samples. Fisher’s exact test was used to compare frequency-variables. Statistical analysis 
was performed with SPSS v17.0.  
Analyses of repeated measures were performed using the univariate general linear model 
approach (GLM procedures) and a compound symmetry covariance structure. The sphericity 
test, Mauchly’s criterion, was used to test departures from the assumption of compound 
symmetry. The sphericity test was consistent with the sphericity assumption in all instances. 
Detailed specifications of statistical analysis in each figure: 
Figure 1A: An analysis of variance model, including exercise group (sedentary, exercise), 
time-point (4 weeks, 8 weeks and 16 weeks) and the interaction term (exercise x time-point) 
was performed. Each heart weight was obtained on different hearts at 4, 8 and 16 weeks, so 
time point was not considered a repeated measures factor. The interaction was not significant, 




so the overall group effect is presented. Exercise group effect was significant and is depicted 
in the figure. 
Figure 1C: A repeated measure analysis model, including exercise group (sedentary, 
exercise), repeating factor ventricular wall (as results were obtained for right ventricular free 
wall, interventricular septum and left ventricular free wall in each heart) and the interaction 
term (exercise x ventricular wall) was performed at each time point (4 weeks, 8 weeks and 16 
weeks). At 4 weeks, neither the interaction term nor the exercise group effect were significant. 
At 8 and 16 weeks, interaction term was significant at the 0.05 level, so comparisons between 
exercise groups within each ventricular wall were done. The Bonferroni-corrected t-test 
(correction factor 3) was used to control for the family-wise error rate by reporting the adjusted 
p-value for every comparison. 
Figure 2B: A repeated measure analysis model, including exercise group (sedentary, 
exercise), repeating factor ventricular wall (since results were obtained for right ventricular free 
wall, interventricular septum and left ventricular free wall in each heart) and the interaction 
term (exercise x ventricular wall) was performed at each time-point. At 4 and 8 weeks, neither 
the interaction term nor the exercise-group effect were significant. At 16 weeks, the interaction 
term was significant at the 0.01 level, so comparisons between exercise groups (sedentary vs 
exercise) within each ventricular wall were done. The Bonferroni-corrected t-test (correction 
factor 3) was used to control for the family-wise error rate by reporting the adjusted p-value for 
every comparison  
Figure 3B A two-way analysis of variance model, including exercise group (sedentary, 
exercise), time-point (4 weeks, 8 weeks or 16 weeks) and the interaction term (exercise x 
ventricular wall) was performed. Each measurement was obtained from separate hearts at 4, 8 
and 16 weeks, so time point was not considered a repeated measures factor. The interaction 
term was significant at the 0.01 level, so comparisons between exercise groups (sedentary vs 
exercise) within each time-point were done. The Bonferroni-adjusted t-test (correction factor 3) 




was used to control for the family-wise error rate by reporting the adjusted p-value for every 
comparison  
Figure 4: A repeated measure analysis of variance model, including exercise group 
(sedentary, exercise), repeating factor cardiac chamber (right atrium, left atrium, right ventricle 
and left ventricle) and the interaction term (exercise x cardiac chamber) was performed for 
each individual fibrosis marker. The interaction term was significant for all the fibrosis markers 
at the 0.05 level, so comparisons between exercise groups (sedentary, exercise) within each 
cardiac chamber were done (four comparisons per chamber). The Bonferroni-corrected t-test 
(correction factor 4) was used to control for the family-wise error rate by reporting the adjusted 
p-value for every comparison 
Figure 5: In Figure 5, all Western blots for all Sed and Ex samples for one region were 
obtained on a single gel to ensure comparability. Because technical factors can greatly affect 
results between gels, the results for one region (which were done on one gel) cannot be 
compared in a valid way to results from another region (which because of limits on the number 
of samples that can be loaded on each gel had to be performed on a separate gel). Therefore, 
there were no repeated measures in Figure 5 and Sed vs Ex were compared by nonpaired t-
test within each region. 
Figure 6: The proportions of inducibility of ventricular arrhythmias were compared with the 
Fisher exact test. 
Figure 7A: An analysis of variance model, including exercise group (sedentary, exercise), 
deconditioning-time (exercise, deconditioning 2 weeks, deconditioning 4 weeks and 
deconditioning 8 weeks) and the interaction term (exercise x deconditioning-time) was 
performed. Each heart weight was obtained on separate hearts at 4 weeks, 8 weeks, 16 
weeks and deconditioning time points, so time point was not considered a repeated measures 
factor. The interaction was significant at the 0.05 level. Consequently, comparisons between 
exercise groups (exercise vs sedentary) within each deconditioining time-point (4 
comparisons), and between the exercise group at different deconditioning-times (Ex vs DEx2, 




Ex vs DEx4 and EX vs DEx8, 3 comparisons) were done. The Bonferroni-adjusted t-test 
(correction factor 7) was used to control for the family-wise error rate by reporting the adjusted 
p-value for every comparison. 
Figure 7B: A repeated measures analysis of variance model, including exercise-deconditioning 
group (sedentary, exercise, deconditioning 2 weeks, deconditioning 4 weeks and 
deconditioning 8 weeks), repeating factor ventricular wall (since results were obtained for right 
ventricular free wall, interventricular septum and left ventricular free wall in each heart) and the 
interaction term (exercise-deconditioning x ventricular wall) was performed. Measurements 
were obtained on separate hearts at 4 weeks, 8 weeks, 16 weeks and deconditioning time 
points, so time point was not considered a repeated measures factor. The interaction was 
significant at the 0.01 level, so comparisons between exercise groups (Sed vs Ex, DEx2, DEx4 
and DEx8, and Ex vs DEx2, DEx4 and DEx8, accounting for 7 comparisons) within each 
ventricular wall (3 ventricular walls) were done. The Bonferroni-corrected t-test (correction 
factor 21) was used to control for the family-wise error rate by reporting the adjusted p-value 
for every comparison. 
Figure 7E and 7F: For these data sets, results for only one sedentary group (corresponding to 
16-week exercise) were available. One-way ANOVA was therefore applied. Measurements 
were obtained on separate hearts at 4 weeks, 8 weeks, 16 weeks and deconditioning time 
points, so time point was not considered a repeated measures factor. The main-effect factor 
was group and was a statistically-significant determinant of the dependent variable. Pairwise 
comparisons (Bonferroni-corrected t-tests) were performed between Sed and each Ex or DEx 
group (4 comparisons) and between Ex and each DEx group (3 comparisons); thus, a 
Bonferroni correction factor of 7 was used. 
Figure 8: A repeated measures analysis of variance model, including exercise-deconditioning 
group (sedentary, exercise, deconditioning 2 weeks, deconditioning 4 weeks, deconditioning 8 
weeks), repeating factor cardiac chamber (right atrium, left atrium, right ventricle, left ventricle) 
and the interaction term (exercise/deconditioning x cardiac chamber) were performed for each 




fibrosis marker (each panel). Measurements were obtained on separate hearts at 4 weeks, 8 
weeks, 16 weeks and deconditioning time points, so time point was not considered a repeated 
measures factor. The interaction term was not significant for any of the fibrosis markers, so 
only the overall group effect is presented. Exercise/deconditioning group effect was significant 
for all fibrosis markers at the level of 0.001, so comparisons among exercise/deconditioning 
groups were obtained (Sed vs Ex, DEx2, DEx4 and DEx8 to look for differences in comparison 
to baseline, and Ex vs DEx2, DEx4 and DEx8 to establish the DEx groups with significant 
recovery, accounting for a total of 7 comparisons per fibrosis marker). The Bonferroni-
corrected t-test (correction factor 7) was7 used to control for the family-wise error rate by 
reporting the adjusted p-value for every comparison.  
Table 1: Comparisons by non-paired t-test between Ex and Sed. 
Table 2: A repeated measures analysis of variance, including exercise group (sedentary, 
exercise), repeating factor time-point (each rat has echocardiographic data at baseline, 8 and 
16 weeks) and the interaction term (exercise x time-point) was performed. Interaction was 
significant at the 0.05 level for LVDd/BW, LVDs/BW, IVS/BW, PW/BW, LV mass/BW, EF, S 
wave PV, IVRTc, E DT, and LADs/BW. For these, comparisons between groups (Ex, Sed) 
were performed at each time-point (baseline, 4 weeks, 8 weeks). The Bonferroni-corrected t-
test was used to control the family-wise error rate (correction factor 3). Interaction was not 
significant but there was a significant group effect (Ex vs Sed) for IVS/LVDd and E veloc.  
Table 3: Comparisons by non-paired t-test between Ex and Sed. 
Online Table 1: A repeated measure analysis of variance model, including exercise group 
(sedentary, exercise), cardiac chamber (right atrium, left atrium, right ventricle and left 
ventricle) and the interaction term (exercise x cardiac chamber) was performed for each 
separate fibrosis markers. Neither interaction term nor exercise group effect was found to be 
significant in any of the fibrosis markers.  




Online Figure 1: An analysis of variance model, including exercise group (sedentary, 
exercise), time-point and the interaction term (exercise x ventricular wall) was performed. 
Analyses were performed on separate hearts at 4, 8 and 16 weeks, so time point was not 
considered a repeated measures factor. Neither interaction term nor exercise group effects 
were found to be significant for any of the time-points. 
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  Right atrium Left atrium Right ventricle Left ventricle 


















1.00 ± 0.40 0.71 ± 0.27 1.00 ± 0.50 1.99 ± 0.48 1.00 ± 0.32 1.04 ± 0.20 1.00 ± 0.38 0.41 ± 0.41 
Fibronectin 
Relative expression 1.00 ± 0.35 0.97 ± 0.37 1.00 ± 0.31 1.42 ± 0.34 1.00 ± 0.62 0.96 ± 0.45 1.00 ± 0.32 0.62 ± 0.21 
MMP2  
Relative expression 1.00 ± 0.42 1.06 ± 0.50 1.00 ± 0.30 2.01 ± 0.77 1.00 ± 0.71 2.28 ± 0.77 1.00 ± 0.47 0.38 ± 0.07 
TIMP1  
Relative expression 1.00 ± 0.67 0.54 ± 0.32 1.00 ± 0.43 1.74 ± 0.42 1.00 ± 0.46 1.07 ± 0.05 1.00 ± 0.48 0.39 ± 0.20 
Proc-I  
Relative expression 1.00 ± 0.76 0.77 ± 0.76 1.00 ± 0.56 2.26 ± 0.11 1.00 ± 0.68 1.33 ± 0.69 1.00 ± 0.66 1.16 ± 0.83 
4 weeks 
Proc-III  
Relative expression 1.00 ± 1.04 0.95 ± 1.04 1.00 ± 0.29 1.62 ± 0.39 1.00 ± 0.61 0.90 ± 0.30 1.00 ± 0.53 1.03 ± 0.53 
TGFβ  
Relative expression 1.00 ± 0.34 1.44 ± 0.62 1.00 ± 0.56 3.76 ± 1.09 1.00 ± 0.56 1.91 ± 0.73 1.00 ± 0.47 2.19 ± 0.43 
Fibronectin 
Relative expression 1.00 ± 1.04 2.57 ± 2.83 1.00 ± 0.39 6.29 ± 2.26 1.00 ± 0.56 5.01 ± 2.62 1.00 ± 0.19 1.89 ± 0.32 
MMP2  
Relative expression 1.00 ± 0.56 1.84 ± 0.83 1.00 ± 0.15 3.42 ± 0.99 1.00 ± 0.51 1.52 ± 0.58 1.00 ± 0.64 0.93 ± 0.36 
TIMP1  
Relative expression 1.00 ± 0.12 1.63 ± 0.77 1.00 ± 0.10 3.97 ± 1.34 1.00 ± 0.43 4.51 ± 1.52 1.00 ± 0.34 3.09 ± 1.32 
Proc-I  
Relative expression 1.00 ± 0.38 3.48 ± 1.33 1.00 ± 0.34 0.98 ± 0.62 1.00 ± 0.43 2.53 ± 0.37 1.00 ± 0.34 1.25 ± 0.24 
8 weeks 
Proc-III  
Relative expression 1.00 ± 0.43 2.55 ± 0.62 1.00 ± 0.38 2.14 ± 1.10 1.00 ± 0.34 1.95 ± 0.29 1.00 ± 0.64 1.34 ± 0.63 
Table 1. mRNA expression of TGF-β1, fibronectin-1, MMP2, TIMP1, procollagen-I, procollagen-III in the four cardiac chambers at 4 and 8 
weeks in Sed and Ex groups. Results are normalized to actin mRNA expression. Values are mean ± SEM of 4 animals (Sed at 4 and 8 weeks) 



















SUPPLEMENTAL FIGURE LEGENDS 
Supplementary Figure 1: (A) Representative picrosirius-red stained photomicrographs of left 
ventricular sections obtained from the interventricular septum and the left ventricular free wall. (B) 
Mean±SEM hydroxyproline-content in left ventricle (whole tissue). n=4 (Sed, 4 and 8 weeks), n=6 
(Sed, 16 weeks), n=5 (Ex, 4 and 8 weeks) and n=8 (Ex 16 weeks). Two-way ANOVA (exercise and 
timepoint as main factors). 
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